Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.740
-0.070 (-3.87%)
At close: Apr 24, 2026, 4:00 PM EDT
1.790
+0.050 (2.87%)
After-hours: Apr 24, 2026, 7:58 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $60.09 million as of April 24, 2026. Its market cap has increased by 139.03% in one year.
Market Cap
60.09M
Enterprise Value
42.63M
1-Year Change
139.03%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $60.09M, a decrease of -3.88%. That is a compound annual growth rate of -0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 60.09M | -34.48% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediciNova | 69.40M |
| OnKure Therapeutics | 68.50M |
| ImageneBio | 67.22M |
| BeyondSpring | 67.03M |
| Grace Therapeutics | 66.69M |
| iBio, Inc. | 66.32M |
| Actuate Therapeutics | 65.92M |
| Cingulate | 65.24M |